Phenylephrine hydrochloride Injection, USP, 10 mg/ mL
Product details
- Phenylephrine hydrochloride Injection, USP, 10 mg/ mL
Company announcement
Provepharm Inc. is recalling one lot of Phenylephrine hydrochloride Injection due to the presence of visible black particulate matter.
The affected product was distributed nationwide to wholesalers.
No adverse events or injuries have been reported as of January 24, 2025.
Risk:
Administration of an injectable product containing particulate matter may cause local irritation or swelling as a response to the foreign material. If the particulate matter enters the blood vessels, it can travel to various organs and potentially blocking blood vessels in the heart, lungs or brain, leading to serious complications such as stroke or even death.
Impacted states: Nationwide
Products:
- Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package)
Contact
For more information, call 866-737-5394 or email provepharm8664@sedgwick.com.
Related recalls
- Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion
- 0.9% Sodium Chloride Injection, USP, 100 mL
- Compounded Glutathione 200 mg/mL 30 mL multidose vial; Myer’s Cocktail 30 mL multidose vial; Tri-Immune Boost 30 mL multidose vial
- Luna G3 APAP (Model LG3600)
- 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container
- 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container